Cargando…

A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis

Cathepsin B (CTSB) is a proteolytic enzyme potentially modulating angiogenic processes and extracellular matrix remodeling. While matrix metalloproteinases are shown to be implicated in tissue fibrosis and vasculopathy associated with systemic sclerosis (SSc), the role of cathepsins in this disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Noda, Shinji, Asano, Yoshihide, Akamata, Kaname, Aozasa, Naohiko, Taniguchi, Takashi, Takahashi, Takehiro, Ichimura, Yohei, Toyama, Tetsuo, Sumida, Hayakazu, Yanaba, Koichi, Tada, Yayoi, Sugaya, Makoto, Kadono, Takafumi, Sato, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285678/
https://www.ncbi.nlm.nih.gov/pubmed/22384200
http://dx.doi.org/10.1371/journal.pone.0032272
_version_ 1782224507447017472
author Noda, Shinji
Asano, Yoshihide
Akamata, Kaname
Aozasa, Naohiko
Taniguchi, Takashi
Takahashi, Takehiro
Ichimura, Yohei
Toyama, Tetsuo
Sumida, Hayakazu
Yanaba, Koichi
Tada, Yayoi
Sugaya, Makoto
Kadono, Takafumi
Sato, Shinichi
author_facet Noda, Shinji
Asano, Yoshihide
Akamata, Kaname
Aozasa, Naohiko
Taniguchi, Takashi
Takahashi, Takehiro
Ichimura, Yohei
Toyama, Tetsuo
Sumida, Hayakazu
Yanaba, Koichi
Tada, Yayoi
Sugaya, Makoto
Kadono, Takafumi
Sato, Shinichi
author_sort Noda, Shinji
collection PubMed
description Cathepsin B (CTSB) is a proteolytic enzyme potentially modulating angiogenic processes and extracellular matrix remodeling. While matrix metalloproteinases are shown to be implicated in tissue fibrosis and vasculopathy associated with systemic sclerosis (SSc), the role of cathepsins in this disease has not been well studied. The aim of this study is to evaluate the roles of CTSB in SSc. Serum pro-CTSB levels were determined by enzyme-linked immunosorbent assay in 55 SSc patients and 19 normal controls. Since the deficiency of transcription factor Fli1 in endothelial cells is potentially associated with the development of SSc vasculopathy, cutaneous CTSB expression was evaluated by immunostaining in Fli1(+/−) and wild type mice as well as in SSc and control subjects. The effects of Fli1 gene silencing and transforming growth factor-β (TGF-β) on CTSB expression were determined by real-time PCR in human dermal microvascular endothelial cells (HDMECs) and dermal fibroblasts, respectively. Serum pro-CTSB levels were significantly higher in limited cutaneous SSc (lcSSc) and late-stage diffuse cutaneous SSc (dcSSc) patients than in healthy controls. In dcSSc, patients with increased serum pro-CTSB levels showed a significantly higher frequency of digital ulcers than those with normal levels. CTSB expression in dermal blood vessels was increased in Fli1(+/−) mice compared with wild type mice and in SSc patients compared with healthy controls. Consistently, Fli1 gene silencing increased CTSB expression in HDMECs. In cultured dermal fibroblasts from early dcSSc, CTSB expression was decreased compared with normal fibroblasts and significantly reversed by TGF-β1 antisense oligonucleotide. In conclusion, up-regulation of endothelial CTSB due to Fli1 deficiency may contribute to the development of SSc vasculopathy, especially digital ulcers, while reduced expression of CTSB in lesional dermal fibroblasts is likely to be associated with skin sclerosis in early dcSSc.
format Online
Article
Text
id pubmed-3285678
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32856782012-03-01 A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis Noda, Shinji Asano, Yoshihide Akamata, Kaname Aozasa, Naohiko Taniguchi, Takashi Takahashi, Takehiro Ichimura, Yohei Toyama, Tetsuo Sumida, Hayakazu Yanaba, Koichi Tada, Yayoi Sugaya, Makoto Kadono, Takafumi Sato, Shinichi PLoS One Research Article Cathepsin B (CTSB) is a proteolytic enzyme potentially modulating angiogenic processes and extracellular matrix remodeling. While matrix metalloproteinases are shown to be implicated in tissue fibrosis and vasculopathy associated with systemic sclerosis (SSc), the role of cathepsins in this disease has not been well studied. The aim of this study is to evaluate the roles of CTSB in SSc. Serum pro-CTSB levels were determined by enzyme-linked immunosorbent assay in 55 SSc patients and 19 normal controls. Since the deficiency of transcription factor Fli1 in endothelial cells is potentially associated with the development of SSc vasculopathy, cutaneous CTSB expression was evaluated by immunostaining in Fli1(+/−) and wild type mice as well as in SSc and control subjects. The effects of Fli1 gene silencing and transforming growth factor-β (TGF-β) on CTSB expression were determined by real-time PCR in human dermal microvascular endothelial cells (HDMECs) and dermal fibroblasts, respectively. Serum pro-CTSB levels were significantly higher in limited cutaneous SSc (lcSSc) and late-stage diffuse cutaneous SSc (dcSSc) patients than in healthy controls. In dcSSc, patients with increased serum pro-CTSB levels showed a significantly higher frequency of digital ulcers than those with normal levels. CTSB expression in dermal blood vessels was increased in Fli1(+/−) mice compared with wild type mice and in SSc patients compared with healthy controls. Consistently, Fli1 gene silencing increased CTSB expression in HDMECs. In cultured dermal fibroblasts from early dcSSc, CTSB expression was decreased compared with normal fibroblasts and significantly reversed by TGF-β1 antisense oligonucleotide. In conclusion, up-regulation of endothelial CTSB due to Fli1 deficiency may contribute to the development of SSc vasculopathy, especially digital ulcers, while reduced expression of CTSB in lesional dermal fibroblasts is likely to be associated with skin sclerosis in early dcSSc. Public Library of Science 2012-02-23 /pmc/articles/PMC3285678/ /pubmed/22384200 http://dx.doi.org/10.1371/journal.pone.0032272 Text en Noda et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Noda, Shinji
Asano, Yoshihide
Akamata, Kaname
Aozasa, Naohiko
Taniguchi, Takashi
Takahashi, Takehiro
Ichimura, Yohei
Toyama, Tetsuo
Sumida, Hayakazu
Yanaba, Koichi
Tada, Yayoi
Sugaya, Makoto
Kadono, Takafumi
Sato, Shinichi
A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
title A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
title_full A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
title_fullStr A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
title_full_unstemmed A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
title_short A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
title_sort possible contribution of altered cathepsin b expression to the development of skin sclerosis and vasculopathy in systemic sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285678/
https://www.ncbi.nlm.nih.gov/pubmed/22384200
http://dx.doi.org/10.1371/journal.pone.0032272
work_keys_str_mv AT nodashinji apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT asanoyoshihide apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT akamatakaname apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT aozasanaohiko apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT taniguchitakashi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT takahashitakehiro apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT ichimurayohei apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT toyamatetsuo apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT sumidahayakazu apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT yanabakoichi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT tadayayoi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT sugayamakoto apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT kadonotakafumi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT satoshinichi apossiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT nodashinji possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT asanoyoshihide possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT akamatakaname possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT aozasanaohiko possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT taniguchitakashi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT takahashitakehiro possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT ichimurayohei possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT toyamatetsuo possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT sumidahayakazu possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT yanabakoichi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT tadayayoi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT sugayamakoto possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT kadonotakafumi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis
AT satoshinichi possiblecontributionofalteredcathepsinbexpressiontothedevelopmentofskinsclerosisandvasculopathyinsystemicsclerosis